China Artificial Organs Market By Organ Type (Artificial Heart, Artificial Kidney, Artificial Pancreas, Others), By Technology (Electronic Bionics, Mechanical), By Material Type (Silicon, Plastic, Steel), By Region, Competition, Forecast & Opportunities, 2028
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationChina Artificial Organs Market By Organ Type (Artificial Heart, Artificial Kidney, Artificial Pancreas, Others), By Technology (Electronic Bionics, Mechanical), By Material Type (Silicon, Plastic, Steel), By Region, Competition, Forecast & Opportunities, 2028
. In 2021, China has over 10 million patients suffering from heart failure, with many requiring heart transplant surgeries.
Technological Advancements
Increasing Occurrences of Organ Failures
Market Segmentation
China artificial organs market is segmented into organ type, technology, material type, company and region. Based on organ type, the market is categorized into artificial heart, artificial kidney, artificial pancreas, and others. Based on technology, the market is bifurcated into electronic bionics, and mechanical. Based on material type, the market is segmented into silicon, plastic, and steel. In terms of region, the market is segmented into South-Central China, South-West China, East China, North-East China, North-West China, and North China.
Market Players
Chengdu Baishixing Science & Technology Industry Co Ltd, Regenovo Biotechnology, Abiomed Inc., Cyfuse Biomedical, Nipro Corporation, Medtronic Inc, Boston Scientific Corporation, Terumo Corporation, Tibion Corporation and Baxter International Inc, are some of the leading companies operating in the market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023E-2028F |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · Organ Type · Technology · Material Type |
| Regional scope | South-Central China, South-West China, East China, North-East China, North-West China, North China |
| Key companies profiled | Chengdu Baishixing Science & Technology Industry Co Ltd, Regenovo Biotechnology, Abiomed Inc., Cyfuse Biomedical, Nipro Corporation, Medtronic Inc, Boston Scientific Corporation, Terumo Corporation, Tibion Corporation and Baxter International Inc |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy